Abstract
Purpose. Retrospective application of allometric scaling techniques to tebufelone, a nonsteroidal antiinflammatory agent, in order to better understand the systemic exposure relationships between the doses administered to the species used in toxicology studies and the doses given to human subjects and patients in clinical studies.
Methods. Non-compartmental estimates of tebufelone's total body volume of distribution during the terminal phase (Vz) and clearance (CL) obtained from intravenous dosing to rat, monkey, dog, and human were allometrically scaled to body weight, and body weight and brain weight, respectively. AUCs determined from single or multiple dose pharmacokinetic studies and from preclinical toxicology studies were plotted versus dose adjusted for bioavailability and divided by allometrically scaled clearance to produce an allometric relationship suggesting a non-linear increase in AUC with dose across the four species.
Results. Segmental linear regression analysis of this relationship indicates a change point associated with an AUC of approximately 2,300 ng-hr/mL. Elevations in serum levels of various liver enzymes or associated signs of hepatic toxicity occur in some, but not all of the animals exposed for more than three weeks in repeat dosing studies at the actual dose that this represents.
Conclusions. The analysis suggests that doses producing tebufelone plasma levels above a certain threshold AUC and duration of exposure to parent tebufelone are associated with increased risks of hepatic effects. Whether this is because metabolic shifts occur at these doses cannot be determined from these data.
Similar content being viewed by others
REFERENCES
D. B. Campbell and R. M. Ings. New approaches to the use of pharmacokinetics in toxicology and drug development. Human Toxicol. 7:469–479 (1988).
R. M. Ings. Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobio. 20:1201–1231 (1990).
J. Mordenti. Man versus beast: pharmacokinetic scaling in mammals. J. Pharm Sci. 75:1028–1040 (1986).
J. M. Mordenti and W. Chappell. The use of interspecies scaling in toxicokinetics. In A. Yacobi, J. P. Skelly and V. K. Batra (eds), Toxicokinetics and New Drug Development, Permagon Press, New York, 1989, pp. 42–96.
W. R. Chappell and J. Mordenti. Extrapolation of Toxicological and Pharmacological Data from Animals to Humans. In B. Testa (ed), Advances in Drug Research, Vol 20, Academic Press Limited, New York, 1991, p. 1–116.
R. L. M. Dobson, D. M. Neal, D. M., B. R. DeMark, B. R., and S. R. Ward. Long-term performance of gas chromatography-tandem mass spectrometry assay for tebufelone {1-(3,5-bis-(1,1-dimethylethyl)-4-hydroxyphenyl)-5-hexyn-1-one} in plasma. Anal. Chem. 62:1819–1824 (1990).
T. H. Eichhold and M. J. Doyle. Determination of tebufelone (pent-4-ynyl 3,5-di-t-butyl-4-hydroxyphenyl ketone), a new anti-inflammatory drug in plasma and tissue using capillary gas chromatography-stable isotope-dilution mass spectrometry. Biomed. Envion. Mass Spectrom. 19:230–234 (1990).
W. A. Ritschel. Handbook of Basic Pharmacokinetics. Third Edition, Drug Intelligence Publications, Inc., Hamilton, IL, 1986.
H. Boxenbaum and J. B. Fertig. Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species. Eur. J. Drug Met. Pharm. 9:177–183 (1984).
D. W. Bacon and D. G. Watts. Estimating the transition between two intersecting straight lines. Biometrika 58:525–534 (1971).
H. Boxenbaum. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab. Rev. 15:1071–1121 (1984).
H. Boxenbaum and R. Ronfeld. Interspecies pharmacokinetic scaling and the Dedrick plots. Am. J. Physiol. 245:R768–775 (1983).
J. W. Paxton, S. N. Kim, and L. R. Whitfield. Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans. Cancer Research 50:2692–2697 (1990).
G. R. Kelm and A. Sakr. Preliminary preformulation investigation of tebufelone, a novel non-steroidal anti-inflammatory drug. Drug Dev. Ind. Pharm. 19:809–826 (1993).
J. Mordenti. Pharmacokinetic scale-up: accurate prediction of human pharmacokinetic profiles from animal data. J. Pharm. Sci. 74:1097–1099 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cruze, C.A., Kelm, G.R. & Meredith, M.P. Interspecies Scaling of Tebufelone Pharmacokinetic Data and Application to Preclinical Toxicology. Pharm Res 12, 895–901 (1995). https://doi.org/10.1023/A:1016273306956
Issue Date:
DOI: https://doi.org/10.1023/A:1016273306956